Stock Information

• Should FDA Approval of Extended EYLEA HD Dosing Flexibility Require Action From Regeneron Pharmaceuticals (REGN) Investors?
  Sat, Apr 11, 2026 3:16 PM
• Regeneron (REGN): Buy, Sell, or Hold Post Q4 Earnings?
  Fri, Apr 10, 2026 1:34 PM
• Morgan Stanley Maintains Equal-Weight on Regeneron Pharmaceuticals, Raises Price Target to $796
  Fri, Apr 10, 2026 11:47 AM
• Lightning Round: Qnity is the most undervalued of the data center stocks right now, says Jim Cramer
  Thu, Apr 9, 2026 7:39 PM
• REGN or ILMN: Which Is the Better Value Stock Right Now?
  Thu, Apr 9, 2026 3:40 PM
• AbbVie: Buy Or Sell Ahead Of Q1 Earnings? It's A Buy, But With Caveats (Upgrade)
  Thu, Apr 9, 2026 2:00 PM
• Bernstein Maintains Outperform on Regeneron Pharmaceuticals, Lowers Price Target to $921
  Wed, Apr 8, 2026 9:36 AM
• Regeneron Pharma Now Expects Q1 GAAP And Non-GAAP Results To Include Acquired IPR&D Charge Of ~$102M On Pre-Tax Basis
  Wed, Apr 8, 2026 7:14 AM
• From Lungs To Nasal Polyps: Sanofi Finds Success With 2-in-1 Inflammation Blocker
  Tue, Apr 7, 2026 7:02 AM
• Regeneron Wins FDA Nod for Extended Eylea HD Dosing Interval
  Mon, Apr 6, 2026 7:06 PM

Financial data not available